NF
Insider selling
Neil F. Mcfarlane sold $225K of Zevra Therapeutics, Inc. (ZVRA) stock
Neil F. Mcfarlane, President and CEO of Zevra Therapeutics, Inc. (ZVRA), sold 20,000 shares of ZVRA stock worth $225K, per an SEC Form 4 filed Oct 13, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 10, 2026, 3 days before it was made public.
ZVRA has moved -0.6% since the trade date, from $11.39 to $11.32 (Oct 12, 2026 close).
- Traded
- Oct 10, 2026
- Disclosed
- Oct 13, 2026
- Filing delay
- 3 days
- Price since
- -0.6%
- Role
- President and CEO
- Source
- SEC Form 4
More ZVRA insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.